Several Spanish and European groups have spent years deepening the knowledge and interpretation of the results obtained with the tumor bio-markers. Dr. Rafael Molina, as leader of the sector, has published and presented in Congresses and Courses, systems to improve the clinical utility of tumor bio-markers, which are reference today. These systems, accessible through more than 200 publications, in scientific journals of recognized prestige, have materialized in the software that we present and that allow to interpret the results of markers as experts in the subject.

Tumor Marker Innovation programs include known information on the major tumor bio-markers, assessing the subject’s situation (demographic and clinical), associated pathologies, the influence of other data (laboratory / image) interprets the correlation of the different bio -markers and evolution over time. The integration of all the data allows to determine the probability of malignant tumor, possible explanations of the result and, above all, the attitude towards them. 

This information is useful to guide the risk of cancer, advise or not more aggressive diagnostic tests (biopsies, image), etc. It is of great interest in patients with suspicion of neoplasia (suspicious images such as lung or liver nodules), with suspicious symptoms (hemoptysis, chest pain), with a high risk of neoplasia (mutations of BRCA 1 and BRCA 2, family history ), To detect tumor recurrences or to assess treatment efficacy.

Tumor Marker Innovation is born from the will of a team of experts in the field of Bio-markers that during the last 30 years has dedicated all its effort to scientific study, clinical research and to the proper evaluation of the results obtained. By improving the knowledge obtained, we can affirm that they help in the diagnosis and follow-up of tumors, improve the interpretation of results and avoid errors that harm the patient, generate confusing data or require other unnecessary examinations (biopsies, Image, etc …).

This work has culminated in the creation of several computer programs that use expert rules obtained through clinical experience and applied research, which allow to evaluate the results of tumor markers in the best possible way (no other current diagnostic method has more success Or contributes more percentage in sensitivity and specified than that contributed by the applications created by Tumor Marker Innovation), giving to the user the tool that will dissipate his doubts in the interpretation as if he consulted to a great team of experts.

A second important point is the willingness of Tumor Marker Innovation to spread this information obtained for its use, a goal they have been carrying out for many years, participating in the organization of more than 50 congresses and training courses for dctors (specialists in urology, gynecology, oncology , Internal medicine, pulmonology) and laboratory personnel around the world.